Novartis Q1 Results Miss Expectations as Core EPS Falls Below Market Estimates
Novartis AG reported its Q1 2025 earnings with core EPS of $1.99, falling short of the $2.10 market estimate. Net sales …
2 articles about 'AI Drug Development'
Novartis AG reported its Q1 2025 earnings with core EPS of $1.99, falling short of the $2.10 market estimate. Net sales …
Google DeepMind has achieved a major new breakthrough in protein folding, with its AI model predicting three-dimensional…